• Home
  • Topic
    • COVID-19
    • New Drugs
    • Oncology
    • Cardiology
    • Metabolism
    • Neuroscience
    • Autoimmune Diseases
    • Infections
    • Rare/Orphan Diseases
    • Drug Safety
  • Section
    • Pharma & Biotech
    • Regulatory
    • Clinical Trials
    • Mergers & Acquisitions
    • Research
    • In the Pipeline
  • BioPharma News
    • About Us
    • Our Team
    • Contact Us
    • Editorial Policy
    • Terms of Use
    • Privacy Policy
  • Subscribe
  • Facebook
  • Twitter
  • LinkedIn
  • Google News
Skip to content
  • Facebook
  • Twitter
  • LinkedIn
  • Google News
BioPharma News

BioPharma News

Biopharmaceutical industry analysis. Credible, reliable, equitable.

Subscribe
  • Home
  • Topic
    • COVID-19
    • New Drugs
    • Oncology
    • Cardiology
    • Metabolism
    • Neuroscience
    • Autoimmune Diseases
    • Infections
    • Rare/Orphan Diseases
    • Drug Safety
  • Section
    • Pharma & Biotech
    • Regulatory
    • Clinical Trials
    • Mergers & Acquisitions
    • Research
    • In the Pipeline
  • BioPharma News
    • About Us
    • Our Team
    • Contact Us
    • Editorial Policy
    • Terms of Use
    • Privacy Policy
  • Subscribe

Cardiology

Hypertension.
Posted inCardiology, Clinical Trials, In the Pipeline

Hypertension Treatment With One Shot Every Six Months

by Julia Mardi and Timur Burkhanayev April 27, 2024May 8, 2024

Zilebesiran and tonlamarsen are advanced and convenient ways to treat high blood pressure.

heart
Posted inCardiology, Pharma & Biotech

Cardior Pharmaceuticals: Advanced Treatment for Heart Failure

by Mark Gubar and Timur Burkhanayev April 5, 2024April 5, 2024

RNA therapy reverses pathological cardiac remodeling, improving heart function and prolonging life.

Posted inCardiology, New Drugs, Rare/Orphan Diseases, Regulatory

Winrevair: Game-Changer in Pulmonary Arterial Hypertension Treatment

by Nik Resovski March 22, 2024April 5, 2024

Sotatercept is the first drug that actually modifies PAH.

Posted inCardiology, Metabolism, New Drugs, Regulatory

Tryvio: Brand New High Blood Pressure Medication

by Tanya von Reuss March 20, 2024April 5, 2024

Aprocitentan for the treatment of resistant arterial hypertension.

heart
Posted inCardiology, Clinical Trials, In the Pipeline, Metabolism

Enlicitide: Very Strong Pill Against ‘Bad’ Cholesterol

by Julia Mardi February 27, 2024April 19, 2024

The oral drug by Merck & Co. smashes all competitors for the treatment and prevention of atherosclerosis.

heart
Posted inCardiology, Clinical Trials, Metabolism

Baxdrostat: New Treatment for Resistant Hypertension

by Tanya von Reuss November 29, 2022April 5, 2024

A selective aldosterone synthase inhibitor for significantly lowering blood pressure.

heart
Posted inCardiology, Metabolism, New Drugs, Regulatory

Camzyos: First Specific Drug to Treat Hypertrophic Cardiomyopathy

by Mark Gubar April 29, 2022April 5, 2024

Mavacamten by Bristol-Myers Squibb is a new breath for all patients with obstructive hypertrophic cardiomyopathy.

Posts pagination

1 2 Older posts
BioPharma News Logo
Biopharmaceutical industry analysis.
© 2025 BioPharma News Powered by Newspack Privacy Policy
  • Facebook
  • Twitter
  • LinkedIn
  • Google News
BioPharma News

Awareness and enlightenment are strengths.

BioPharma News is an amazing and trustworthy non-profit data analysis service that provides honest and objective reporting on the Pharma & Biotech industry. We would like to invite you to sign up for our weekly Newsletter to stay informed and uptodate.

Please check your inbox or spam folder for an email from [email protected] to confirm your subscription.

×